Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Impax Laboratories said that the FDA has granted final approval for generic versions of Pharmacia and Upjohn's anxiety disorder drug Xanax XR in 0.5mg, 1mg, 2mg and 3mg dose strengths.
Subscribe to our email newsletter
California-based Impax said that it plans to launch the product soon. US sales of the combined branded and generic 0.5mg, 1mg, 2mg and 3mg dosage forms were approximately $51 million in the 12 months ended March 2007, according to Wolters Kluwer Health.
“This is our third FDA approval this year and we are looking forward to adding our generic Xanax XR to the growing portfolio of our marketed products,” said Larry Hsu, Impax’s president and CEO.